The competition for generics' 180-day marketing exclusivity is fierce, and Dr. Reddy's Laboratories filed the first court case calling into question FDA's methods for determining exclusivity on a patent-by-patent basis.
Amy S. Manning
Advertisement
Amy S. Manning, Esq.,is an associate in the Intellectual Property Practice Group in the New York office of Coudert Brothers LLP.
Articles by Amy S. Manning
Advertisement
Latest Updated Articles
Generics Battle Heats UpPublished: April 1st 2003 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
How Do Global Pharma Growth Strategies Differ from Domestic Strategies?
2
The 49th State: Q&A with Mark Mikhael
3
Novo Nordisk’s New Board: A Shift Back to Science & Operations But a Step Away From Commercial Priorities?
4
How Can Harvard Business School Students and Alumni Prepare for Their Long-Term Career Journeys in an Accelerating AI-Focused Society?
5
